VITRASE (ISTA Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the VITRASE drug offered from ISTA Pharmaceuticals, Inc.. This Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ISTA Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | hyaluronidase, ovine |
SUBSTANCE NAME: | HYALURONIDASE, OVINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-02-01 |
END MARKETING DATE: | 0000-00-00 |
VITRASE HUMAN PRESCRIPTION DRUG Details:
Item Description | VITRASE from ISTA Pharmaceuticals, Inc. |
LABELER NAME: | ISTA Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200([USP’U]/mL) |
START MARKETING DATE: | 2005-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67425-002_ec2bd376-a904-8ef4-0daf-0b071de70e9c |
PRODUCT NDC: | 67425-002 |
APPLICATION NUMBER: | NDA021640 |
Other HYALURONIDASE, OVINE Pharmaceutical Manufacturers / Labelers: